Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 28, 2009
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
Alessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
Immunology
|
January 3, 2013
Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell development
Alessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer
Alessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.
Journal of Neuroinflammation
|
September 12, 2018
The human microglial HMC3 cell line: where do we stand? A systematic literature review
Cinzia Dello Russo, Natalia Cappoli, Isabella Coletta, et al.
Cancer Immunology, Immunotherapy : CII
|
January 4, 2020
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2020
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, et al.
Journal of Cellular Physiology
|
April 20, 2018
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
Alessandro Russo, Tindara Franchina, Giuseppina R R Ricciardi, et al.
Translational Oncology
|
February 16, 2018
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer
Enrica Martinelli, Andrea Fattorossi, Alessandra Battaglia, et al.
Gynecologic and Obstetric Investigation
|
October 8, 2003
Doppler velocimetry and cytofluorimetric analysis in uterine myomas
Antonia Carla Testa, Francesco Pomini, Andrea Fattorossi, et al.
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|
September 24, 2024
Percutaneous femoral venoarterial ECMO decannulation at the bedside using the Manta vascular closure device
Alessandro Affronti, Isidoro Di Bella, Angelo Pisani, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Cancer Immunology, Immunotherapy : CII
|
January 28, 2009
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
Alessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
Immunology
|
January 3, 2013
Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell development
Alessandra Battaglia, Alexia Buzzonetti, Cinzia Baranello, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer
Alessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.
Journal of Neuroinflammation
|
September 12, 2018
The human microglial HMC3 cell line: where do we stand? A systematic literature review
Cinzia Dello Russo, Natalia Cappoli, Isabella Coletta, et al.
Cancer Immunology, Immunotherapy : CII
|
January 4, 2020
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2020
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, et al.
Journal of Cellular Physiology
|
April 20, 2018
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
Alessandro Russo, Tindara Franchina, Giuseppina R R Ricciardi, et al.
Translational Oncology
|
February 16, 2018
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer
Enrica Martinelli, Andrea Fattorossi, Alessandra Battaglia, et al.
Gynecologic and Obstetric Investigation
|
October 8, 2003
Doppler velocimetry and cytofluorimetric analysis in uterine myomas
Antonia Carla Testa, Francesco Pomini, Andrea Fattorossi, et al.
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|
September 24, 2024
Percutaneous femoral venoarterial ECMO decannulation at the bedside using the Manta vascular closure device
Alessandro Affronti, Isidoro Di Bella, Angelo Pisani, et al.
Page
of 5